価格表

在庫・価格 : 2024年06月01日 16時35分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Rad51C, Mouse-Mono(2H11/6)
データシート
NB100-177 NOVノバス バイオロジカルス
Novus biologicals, LLC
100 μl ¥91,000
(未発注)
追加

在庫・価格 : 2024年06月01日 16時35分 現在

Anti-Rad51C, Mouse-Mono(2H11/6)

  • 商品コード:NB100-177
  • メーカー:NOV
  • 包装:100μl
  • 価格: ¥91,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Masson JY et al. Complex formation by the human RAD51C and XRCC3 recombination repair proteins. Proc. Natl. Acad. Sci. U.S.A. 2001 Jul;98(15):8440-6
Masson JY et al
2001/01/01
Western Blot, Immunoprecipitation, Human PubMed
2 Masson JY et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001 Dec;15(24):3296-307
Masson JY et al
2001/01/01
Immunoprecipitation, human PubMed
3 French CA et al. Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J. Biol. Chem. 2002 May;277(22):19322-30
French CA et al
2002/01/01
Western Blot, Immunoflouroescence, Immunoprecipitation, Human PubMed
4 Maacke H et al. Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen. J. Cancer Res. Clin. Oncol. 2002 Apr;128(4):219-22
Maacke H et al
2002/01/01
Immunohistochemistry, Western Blot, Human PubMed
5 Godthelp BC et al. Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res. 2002 May;30(10):2172-82
Godthelp BC et al
2002/01/01
Western Blot, Immunofluorescence, Hamster PubMed
6 Lambert S et al. Inactivation of the RAD51 recombination pathway stimulates UV-induced mutagenesis in mammalian cells. Oncogene 2002 Jun;21(25):4065-9
Lambert S et al
2002/01/01
Hamster PubMed
7 Liu Y et al. RAD51C is required for Holliday junction processing in mammalian cells. Science 2004 Jan;303(5655):243-6
Liu Y et al
2004/01/01
Human PubMed
8 Fan R et al. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression. Cancer Res. 2004 Dec;64(23):8526-33
Fan R et al
2004/01/01
PubMed
9 Nagaraju G et al. Differential regulation of short- and long-tract gene conversion between sister chromatids by Rad51C. Mol. Cell. Biol. 2006 Nov;26(21):8075-86
Nagaraju G et al
2006/01/01
PubMed
10 Kuznetsov S et al. RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females. J. Cell Biol. 2007 Feb;176(5):581-92
Kuznetsov S et al
2007/01/01
PubMed
11 Chan N et al. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res. 2008 Jan;68(2):605-14
Chan N et al
2008/01/01
PubMed
12 Dosanjh MK et al. Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res. 1998 Mar;26(5):1179-84
Dosanjh MK et al
1998/01/01
Yeast PubMed
13 Sage JM et al. Discovery of a novel function for human Rad51: maintenance of the mitochondrial genome. J. Biol. Chem. 2010 Jun;285(25):18984-90
Sage JM et al
2010/01/01
PubMed
14 Shammas MA et al. Dysfunctional homologous recombination mediates genomic instability and progression in myeloma. Blood 2009 Mar;113(10):2290-7
Shammas MA et al
2009/01/01
PubMed
15 Bennett BT et al. Cellular localization of human Rad51C and regulation of ubiquitin-mediated proteolysis of Rad51. J. Cell. Biochem. 2005 Dec;96(6):1095-109
Bennett BT et al
2005/01/01
PubMed
16 Gildemeister OS et al. Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C. J. Biol. Chem. 2009 Nov;284(46):31945-52
Gildemeister OS et al
2009/01/01
PubMed
17 Mao Z et al. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence. Proc. Natl. Acad. Sci. U.S.A. 2012 Jul;109(29):11800-5
Mao Z et al
2012/01/01
Species: Human, Applications: WB PubMed
18 Wang Y et al. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res. 2012 Aug;72(16):4037-46
Wang Y et al
2012/01/01
Species: Human, Applications: WB PubMed
19 Jensen RB et al. BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage. DNA Repair (Amst.) 2013 Apr;12(4):306-11
Jensen RB et al
2013/01/01
Species: Human, Applications: WB PubMed
20 Min A et al. RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib. Mol. Cancer Ther. 2013 Jun;12(6):865-77
Min A et al
2013/01/01
Species: Human, Applications: WB, IHC-P, ICC/IF PubMed
21 Park JY et al. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene 2013 Oct;
Park JY et al
2013/01/01
PubMed
22 Huang JW et al. Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity. Mol. Cancer Res. 2013 Dec;11(12):1564-73
Huang JW et al
2013/01/01
PubMed
23 Chun J et al. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway. Mol. Cell. Biol. 2013 Jan;33(2):387-95
Chun J et al
2013/01/01
Species: Human PubMed
24 Gayarre J et al. Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes. Br. J. Cancer 2017 Sep;117(7):1048-1062
Gayarre J et al
2017/01/01
Species: Human, Applications: WB PubMed
25 Lai X et al. MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells. Nat Commun 2017 07;8:15983
Lai X et al
2017/01/01
Species: Human, Applications: WB PubMed
26 Han J et al. BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability. Nat Commun 2017 11;8(1):1470
Han J et al
2017/01/01
Species: Human, Applications: ICC/IF PubMed
27 Wu D et al. Olaquindox disrupts tight junction integrity and cytoskeleton architecture in mouse Sertoli cells. Oncotarget 2017 Oct;8(51):88630-88644
Wu D et al
2017/01/01
Species: Mouse, Applications: WB PubMed
28 Parmar K et al. The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition. Clin Cancer Res 2019 10;25(20):6127-6140
Parmar K et al
2019/01/01
PubMed
29 Mohan M et al. Human RAD51 paralogue RAD51C fosters repair of alkylated DNA by interacting with the ALKBH3 demethylase. Nucleic Acids Res 2019 12;47(22):11729-11745
Mohan M et al
2019/01/01
PubMed
30 Min A et al. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells. Breast Cancer Res 2015 Mar;17:33
Min A et al
2015/01/01
PubMed
31 Hurley RM et al. Characterization of a <i>RAD51C</i>-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance. NAR Cancer 2021 Sep;3(3):zcab028
Hurley RM et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Masson JY et al. Complex formation by the human RAD51C and XRCC3 recombination repair proteins. Proc. Natl. Acad. Sci. U.S.A. 2001 Jul;98(15):8440-6
    Masson JY et al
    2001/01/01
  • 備考:
    Western Blot, Immunoprecipitation, Human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Masson JY et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001 Dec;15(24):3296-307
    Masson JY et al
    2001/01/01
  • 備考:
    Immunoprecipitation, human
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    French CA et al. Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J. Biol. Chem. 2002 May;277(22):19322-30
    French CA et al
    2002/01/01
  • 備考:
    Western Blot, Immunoflouroescence, Immunoprecipitation, Human
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Maacke H et al. Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen. J. Cancer Res. Clin. Oncol. 2002 Apr;128(4):219-22
    Maacke H et al
    2002/01/01
  • 備考:
    Immunohistochemistry, Western Blot, Human
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Godthelp BC et al. Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res. 2002 May;30(10):2172-82
    Godthelp BC et al
    2002/01/01
  • 備考:
    Western Blot, Immunofluorescence, Hamster
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Lambert S et al. Inactivation of the RAD51 recombination pathway stimulates UV-induced mutagenesis in mammalian cells. Oncogene 2002 Jun;21(25):4065-9
    Lambert S et al
    2002/01/01
  • 備考:
    Hamster
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Liu Y et al. RAD51C is required for Holliday junction processing in mammalian cells. Science 2004 Jan;303(5655):243-6
    Liu Y et al
    2004/01/01
  • 備考:
    Human
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Fan R et al. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression. Cancer Res. 2004 Dec;64(23):8526-33
    Fan R et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Nagaraju G et al. Differential regulation of short- and long-tract gene conversion between sister chromatids by Rad51C. Mol. Cell. Biol. 2006 Nov;26(21):8075-86
    Nagaraju G et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kuznetsov S et al. RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females. J. Cell Biol. 2007 Feb;176(5):581-92
    Kuznetsov S et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Chan N et al. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res. 2008 Jan;68(2):605-14
    Chan N et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Dosanjh MK et al. Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res. 1998 Mar;26(5):1179-84
    Dosanjh MK et al
    1998/01/01
  • 備考:
    Yeast
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Sage JM et al. Discovery of a novel function for human Rad51: maintenance of the mitochondrial genome. J. Biol. Chem. 2010 Jun;285(25):18984-90
    Sage JM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Shammas MA et al. Dysfunctional homologous recombination mediates genomic instability and progression in myeloma. Blood 2009 Mar;113(10):2290-7
    Shammas MA et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Bennett BT et al. Cellular localization of human Rad51C and regulation of ubiquitin-mediated proteolysis of Rad51. J. Cell. Biochem. 2005 Dec;96(6):1095-109
    Bennett BT et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Gildemeister OS et al. Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C. J. Biol. Chem. 2009 Nov;284(46):31945-52
    Gildemeister OS et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Mao Z et al. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence. Proc. Natl. Acad. Sci. U.S.A. 2012 Jul;109(29):11800-5
    Mao Z et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Wang Y et al. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res. 2012 Aug;72(16):4037-46
    Wang Y et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Jensen RB et al. BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage. DNA Repair (Amst.) 2013 Apr;12(4):306-11
    Jensen RB et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Min A et al. RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib. Mol. Cancer Ther. 2013 Jun;12(6):865-77
    Min A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P, ICC/IF
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Park JY et al. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene 2013 Oct;
    Park JY et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Huang JW et al. Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity. Mol. Cancer Res. 2013 Dec;11(12):1564-73
    Huang JW et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Chun J et al. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway. Mol. Cell. Biol. 2013 Jan;33(2):387-95
    Chun J et al
    2013/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Gayarre J et al. Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes. Br. J. Cancer 2017 Sep;117(7):1048-1062
    Gayarre J et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Lai X et al. MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells. Nat Commun 2017 07;8:15983
    Lai X et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Han J et al. BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability. Nat Commun 2017 11;8(1):1470
    Han J et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Wu D et al. Olaquindox disrupts tight junction integrity and cytoskeleton architecture in mouse Sertoli cells. Oncotarget 2017 Oct;8(51):88630-88644
    Wu D et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Parmar K et al. The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition. Clin Cancer Res 2019 10;25(20):6127-6140
    Parmar K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Mohan M et al. Human RAD51 paralogue RAD51C fosters repair of alkylated DNA by interacting with the ALKBH3 demethylase. Nucleic Acids Res 2019 12;47(22):11729-11745
    Mohan M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Min A et al. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells. Breast Cancer Res 2015 Mar;17:33
    Min A et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Hurley RM et al. Characterization of a <i>RAD51C</i>-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance. NAR Cancer 2021 Sep;3(3):zcab028
    Hurley RM et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed